Skip to content
10-Q

Quarterly Report

KIORA PHARMACEUTICALS INC KPHMW KPRX

0001372514-25-000061

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 3.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.17M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.03M sh
Capex Q2 2025 · Jun 30, 2025 $32.2K
Capex Q2 2025 · Jun 30, 2024 $51.29K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.51M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $9.89M
Short Term Investments Q2 2025 · Jun 30, 2025 $19.64M
Short Term Investments Q2 2025 · Dec 31, 2024 $23M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.03M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.79M
Stockholders Equity Q2 2025 · Jun 30, 2025 $22.13M
Stockholders Equity Q2 2025 · Mar 31, 2025 $23.7M
Stockholders Equity Q2 2025 · Dec 31, 2024 $25.76M
Stockholders Equity Q2 2025 · Jun 30, 2024 $33.1M
Stockholders Equity Q2 2025 · Mar 31, 2024 $34.9M
Stockholders Equity Q2 2025 · Dec 31, 2023 $6.11M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.19M
Current Liabilities Q2 2025 · Dec 31, 2024 $6.01M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.82M
Total Liabilities Q2 2025 · Dec 31, 2024 $10.72M
Current Assets Q2 2025 · Jun 30, 2025 $24.74M
Current Assets Q2 2025 · Dec 31, 2024 $29.71M
Total Assets Q2 2025 · Jun 30, 2025 $31.95M
Total Assets Q2 2025 · Dec 31, 2024 $36.48M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.10
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.53
Eps Diluted Q2 2025 · Jun 30, 2024 $2.79
Eps Basic Q2 2025 · Jun 30, 2025 −$0.54
Eps Basic Q2 2025 · Jun 30, 2025 −$1.10
Eps Basic Q2 2025 · Jun 30, 2024 −$0.53
Eps Basic Q2 2025 · Jun 30, 2024 $3.19
Sga Expense Q2 2025 · Jun 30, 2025 $1.35M
Sga Expense Q2 2025 · Jun 30, 2025 $2.84M
Sga Expense Q2 2025 · Jun 30, 2024 $1.54M
Sga Expense Q2 2025 · Jun 30, 2024 $2.83M
Rd Expense Q2 2025 · Jun 30, 2025 $2.59M
Rd Expense Q2 2025 · Jun 30, 2025 $5.12M
Rd Expense restated Q2 2025 · Jun 30, 2024 $2.05M
Rd Expense restated Q2 2025 · Jun 30, 2024 $3.73M
Net Income Q2 2025 · Jun 30, 2025 −$2.15M
Net Income Q2 2025 · Jun 30, 2025 −$4.35M
Net Income Q2 2025 · Jun 30, 2024 −$2.22M
Net Income Q2 2025 · Jun 30, 2024 $11.23M
Operating Income Q2 2025 · Jun 30, 2025 −$2.4M
Operating Income Q2 2025 · Jun 30, 2025 −$4.73M
Operating Income Q2 2025 · Jun 30, 2024 −$2.54M
Operating Income Q2 2025 · Jun 30, 2024 $10.68M